Is Pfizer Stock a "Value Trap" or a Generational Opportunity?

Pfizer is an over-100-year-old drug company going through a rough patch, which has happened before.

Pfizer’s Broader Pneumococcal Vaccine Push Might Change The Case For Investing In Pfizer (PFE)

Earlier in May 2026, Pfizer reported positive Phase 2 results for its investigational 25‑valent pneumococcal conjugate vaccine in infants, showing strong immune responses versus PREVNAR 20 and ...

Fact Check: Hantavirus infection is not a confirmed side effect of Pfizer’s COVID-19 vaccine

There are no hantaviruses in the ingredient list of the Pfizer COVID vaccine, now called Comirnaty. According to Pfizer’s ...